We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Rate of Myocarditis in Vaccinated Boys Slightly Higher Than Thought, Israeli Study Finds
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Trending > Rate of Myocarditis in Vaccinated Boys Slightly Higher Than Thought, Israeli Study Finds
Rate of Myocarditis in Vaccinated Boys Slightly Higher Than Thought, Israeli Study Finds
Trending

Rate of Myocarditis in Vaccinated Boys Slightly Higher Than Thought, Israeli Study Finds

Last updated: January 27, 2022 10:26 am
Editorial Board Published January 27, 2022
Share
SHARE
26virus briefing myocarditis facebookJumbo v2

Boys aged 12 to 15 have a small but increased risk of heart problems after receiving a second dose of the Pfizer-BioNTech vaccine, Israeli researchers reported on Wednesday.

Myocarditis, or inflammation of the heart muscle, occurred in one of 12,361 boys of that age group within a week of receiving a second dose, the study found.

The cases were mild, and the side effect remains uncommon. Moreover, several studies have shown that the risk of myocarditis after Covid is much higher than that after vaccination.

Still, the Israeli figure is higher than the Centers for Disease Control and Prevention estimate of one case per 16,129 vaccinated adolescents aged 12 to 17. Israeli researchers previously reported that nearly 11 of every 100,000 boys and men aged 16 to 29 were at heightened risk of myocarditis after vaccination.

Although the new results are based only on the Pfizer-BioNTech vaccine, other studies have found that the incidence of myocarditis may be higher with the mRNA vaccine made by Moderna. Myocarditis can manifest as chest pain, shortness of breath and the feeling of having a fast-beating, fluttering or pounding heart, according to the C.D.C.

Some European countries paused the use of the Moderna vaccine in male adolescents because of the risk. In the United States, only the Pfizer-BioNTech vaccine is authorized for use in adolescents and children 5 and older.

Concern about heart inflammation may have prompted the Food and Drug Administration to ask Pfizer-BioNTech and Moderna to enroll more children in their vaccine trials. Even so, Pfizer’s trial of the vaccine included just 567 boys aged 12 to 15 — too few to detect uncommon side effects.

The new study tracked hospitalizations for myocarditis from June 2 to Oct. 20, 2021, through a surveillance system of Israel’s Health Ministry. During that time, 404,407 adolescents ages 12 to 15 received a vaccine dose, and 326,463 adolescents received a second dose.

The researchers found 18 reports of hospitalization for myocarditis. They excluded two of the cases because of “reasonable alternative diagnoses” and two others because they occurred 46 and 70 days after the second dose — too long after the vaccination to be related, the researchers said.

Of the remaining 14, one was in an unvaccinated adolescent, one in an adolescent who had received the first vaccine dose within 21 days, and 12 cases within a week after the second dose. The results were published in The New England Journal of Medicine.

All of the cases were clinically mild, and the adolescents were hospitalized for an average of three days. None were readmitted during 30 days of follow-up.

The researchers estimated that myocarditis occurs in 0.56 male adolescents per 100,000 after a first dose, and in 8.09 per 100,000 after a second dose. The corresponding risk among girls of that age was negligible.

The study may have underestimated the risk of myocarditis, because the researchers looked only at boys who were hospitalized for the condition.

You Might Also Like

Reserving the Future with GreenFlow: Glacier Vault’s Global Education Initiative

Debut Novel The Revenant’s Mark Blends Revolutionary War History with Dark Fantasy in a Haunting Tale of Resurrection and Reckoning

GARI Emerges as a Global Leader in Research Mentorship and Scholarly InnovationAustin, Texas

“A Family’s Fight to Reclaim Their Legacy”

Streamline, Scale, Succeed: Why Global Enterprises Are Moving to Odoo ERP

TAGGED:Centers for Disease Control and PreventionCoronavirus (2019-nCoV)Drugs (Pharmaceuticals)HeartTeenagers and AdolescenceThe Washington MailVaccination and Immunization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Emily Henry, Author of ‘Book Lovers,’ on the Appeal of Travel
Lifestyle

Emily Henry, Author of ‘Book Lovers,’ on the Appeal of Travel

Editorial Board July 26, 2022
PBS suing Trump administration over defunding, three days after NPR filed comparable case
3D bioprinting is booming however patent legal guidelines could also be holding it again
Seven Decades Later, the 1950 Census Bares Its Secrets
Andy Paley, who produced for Brian Wilson and composed for ‘SpongeBob SquarePants,’ dies at 72

You Might Also Like

Beloved Children’s Book 𝑻𝒉𝒆 𝑴𝒂𝒑 𝑴𝒚 𝑴𝒐𝒎𝒔 𝑮𝒂𝒗𝒆 𝑴𝒆 Returns to Best-Seller Status Years After Its Release — and Fans Are Begging for More
LifestyleTrending

Beloved Children’s Book 𝑻𝒉𝒆 𝑴𝒂𝒑 𝑴𝒚 𝑴𝒐𝒎𝒔 𝑮𝒂𝒗𝒆 𝑴𝒆 Returns to Best-Seller Status Years After Its Release — and Fans Are Begging for More

June 23, 2025
Model With a Mission: In Conversation With Maurice Giovanni
EntertainmentTrending

Model With a Mission: In Conversation With Maurice Giovanni

June 22, 2025
AI Architecture Pioneer: How Abdul Muqtadir Mohammed Is Reshaping Cloud, Code, and Supply Chains
TechnologyTrending

AI Architecture Pioneer: How Abdul Muqtadir Mohammed Is Reshaping Cloud, Code, and Supply Chains

June 17, 2025
Global Security and Health Resilience: How AI-Driven Systems Could Reinvent National Safety—And the Visionary Behind the Shift
Trending

Global Security and Health Resilience: How AI-Driven Systems Could Reinvent National Safety—And the Visionary Behind the Shift

June 16, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?